150 related articles for article (PubMed ID: 12047970)
1. Treatment of hypereosinophilic syndrome with imatinib mesilate.
Gleich GJ; Leiferman KM; Pardanani A; Tefferi A; Butterfield JH
Lancet; 2002 May; 359(9317):1577-8. PubMed ID: 12047970
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome.
Cortes J; Ault P; Koller C; Thomas D; Ferrajoli A; Wierda W; Rios MB; Letvak L; Kaled ES; Kantarjian H
Blood; 2003 Jun; 101(12):4714-6. PubMed ID: 12595304
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment of hypereosinophilic syndrome with imatinib mesylate.
Salem Z; Zalloua PA; Chehal A; Bitar N; Abboud M; Kadri A; Chami B; Bazarbachi A
Hematol J; 2003; 4(6):410-2. PubMed ID: 14671612
[TBL] [Abstract][Full Text] [Related]
4. Hypereosinophilic syndrome.
Roufosse FE; Goldman M; Cogan E
N Engl J Med; 2003 Jun; 348(26):2687; author reply 2687. PubMed ID: 12826646
[No Abstract] [Full Text] [Related]
5. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders.
Pardanani A; Reeder T; Porrata LF; Li CY; Tazelaar HD; Baxter EJ; Witzig TE; Cross NC; Tefferi A
Blood; 2003 May; 101(9):3391-7. PubMed ID: 12506022
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment with imatinib mesylate of hypereosinophilic syndrome (chronic eosinophilic leukemia) with myelofibrosis.
Ishii Y; Ito Y; Kuriyama Y; Tauchi T; Ohyashiki K
Leuk Res; 2004 May; 28 Suppl 1():S79-80. PubMed ID: 15036947
[No Abstract] [Full Text] [Related]
7. Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis.
Musto P; Falcone A; Sanpaolo G; Bodenizza C; Perla G; Minervini MM; Cascavilla N; Dell'Olio M; La Sala A; Mantuano S; Melillo L; Nobile M; Scalzulli PR; Bisceglia M; Carella AM
Leuk Lymphoma; 2004 Jun; 45(6):1219-22. PubMed ID: 15360005
[TBL] [Abstract][Full Text] [Related]
8. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
Garg A; Duggal L; Aggarwal S; Jain N
J Assoc Physicians India; 2006 Nov; 54():883-6. PubMed ID: 17249259
[TBL] [Abstract][Full Text] [Related]
9. Reversal of hypereosinophilic syndrome and lymphomatoid papulosis with mepolizumab and imatinib.
Koury MJ; Newman JH; Murray JJ
Am J Med; 2003 Nov; 115(7):587-9. PubMed ID: 14599646
[No Abstract] [Full Text] [Related]
10. [Treatment of idiopathic hypereosinophilic syndrome with imatinib].
Sørensen AL; Larsen H
Ugeskr Laeger; 2008 Jan; 170(4):254. PubMed ID: 18282461
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate: a case report.
Tan D; Hwang W; Ng HJ; Goh YT; Tan P
Int J Hematol; 2004 Jul; 80(1):75-7. PubMed ID: 15293573
[TBL] [Abstract][Full Text] [Related]
12. Myeloproliferative hypereosinophilic syndrome presenting as cardiac failure and response to imatinib.
Desai N; Morkhandikar S; Sahay R; Jijina F; Patil P
Am J Ther; 2014; 21(2):e35-7. PubMed ID: 24603276
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of imatinib mesylate in a patient with idiopathic hypereosinophilic syndrome and severe heart involvement.
Anghel G; De Rosa L; Ruscio C; Petti N; Riccardi M; Severino A; Majolino I
Tumori; 2005; 91(1):67-70. PubMed ID: 15850007
[TBL] [Abstract][Full Text] [Related]
14. A case of myeloid neoplasm associated with eosinophilia and KIAA1509-PDGFRβ responsive to combination treatment with imatinib mesylate and prednisolone.
Wang JR; Yen CC; Gau JP; Hsiao LT; Liu CY; Pai JT; Tzeng CH; Teng HW
J Clin Pharm Ther; 2010 Dec; 35(6):733-6. PubMed ID: 21054467
[TBL] [Abstract][Full Text] [Related]
15. [Complete remission with imatinib mesylate (Glivec) of an idiopathic hypereosinophilic syndrome associated with a cutaneous mastocytosis after failure of interferon-alpha].
Pottier P; Planchon B; Grossi O
Rev Med Interne; 2003 Aug; 24(8):542-6. PubMed ID: 12888176
[TBL] [Abstract][Full Text] [Related]
16. Isolated bilateral uveitis in child with hypereosinophilic syndrome.
Ramzan M; Chopra Y; Grover AK; Yadav SP
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e465-7. PubMed ID: 24390454
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate treatment in two patients with idiopathic hypereosinophilic syndrome.
Payne SM; Kovacs MJ
Ann Pharmacother; 2004; 38(7-8):1215-8. PubMed ID: 15187212
[TBL] [Abstract][Full Text] [Related]
18. Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
Hofmann SC; Technau K; Müller AM; Lübbert M; Bruckner-Tuderman L
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S68-72. PubMed ID: 17097375
[TBL] [Abstract][Full Text] [Related]
19. The hypereosinophilic syndrome and the biology of cancer.
Schwartz RS
N Engl J Med; 2003 Mar; 348(13):1199-200. PubMed ID: 12660383
[No Abstract] [Full Text] [Related]
20. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
Moles MP; Landry J; Roche-Lestienne C; Godon A; Schmidt-Tanguy A; Gardembas M; Le Clech C; Verret JL; Zandecki M; Blanchet O
Ann Biol Clin (Paris); 2005; 63(3):317-22. PubMed ID: 15951264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
